Moderna ($MRNA) Insider Trading & Smart Money Activity
Moderna, Inc. ($MRNA) has 3 insider trades, 3 congress trades, 7 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($17.01M), net -$17.01M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$17.01M
- Congress trades (12 mo)
- 3
- 13F moves on file
- 7
- Analyst ratings on file
- 2
MRNA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 1 |
| Q3 2026 | 0 | 0 | 1 / 2 | 0 / 0 |
| Q4 2026 | 0 | 2 · $17.01M | 0 / 0 | 3 / 3 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MRNA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Y-Intercept (Hong Kong) | Reduced | -81.27K sh | $11.28M | — | ||||||
| 13F | Kintegral Advisory | New | +2.79K sh | $536.50K | — | ||||||
| 13F | Elser Financial Planning | New | +1.33K sh | $257.08K | Read | ||||||
| 13F | Banque Pictet & Cie | Reduced | -548.14K sh | $414.27M | Read | ||||||
| Insider | Stephen HogePresident | Sell (Open-market sale) 10b5-1 | 39.15K sh | $8.64M | -2.34% | SEC | Read | ||||
| 13F | V-Square Quantitative Management | Reduced | -3.65K sh | $554.02K | — | ||||||
| 13F | Cohen Klingenstein | New | +2.10K sh | $404.40K | Read | ||||||
| Insider | Stephen HogePresident | Sell (Open-market sale) 10b5-1 | 39.22K sh | $8.37M | -2.39% | SEC | Read | ||||
| Analyst | Citigroup | Lowers to Sell | PT $80 | +2.0% | — | ||||||
| Congress | Maria Elvira Salazar | Sale | $1,001 - $15,000 | -3.0% | Read | ||||||
| Congress | Maria Elvira Salazar | Sale | $1,001 - $15,000 | -14.2% | -11.7% | — | |||||
| Congress | Maria Elvira Salazar | Purchase | $1,001 - $15,000 | -14.2% | -11.7% | — | |||||
| Analyst | Piper Sandler | Reiterates to buy | PT $77 | +21.6% | -17.3% | Read | |||||
| Insider | Stephen HogePresident | Buy (Option exercise) | 53.34K sh | $1.02M | +13.8% | +31.0% | Read | ||||
| 13F | Baillie Gifford | Reduced | -594.64K sh | $1.40B | -9.8% | -12.4% | — |
1W / 1M / 6M = how MRNA moved from the trade or filing date.
Insider trading in MRNA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Stephen Hoge | President | 3 | -$17.01M | 1.64M | Oct 15, 2026 |
Members of Congress trading MRNA
Institutions moving MRNA (13F)
Analyst ratings on MRNA
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Citigroup | Lowers | Sell | $60 → $80 | +2.0% | — | |||
| Piper Sandler | Reiterates | buy | $77 | +21.6% | -17.3% | Read |
Frequently asked questions
Are MRNA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $17.01M, a net -$17.01M.
What is the latest insider trade in MRNA?
Stephen Hoge, President filed a sell (open-market sale) of 39.15K sh worth $8.64M on Oct 15, 2026.
Which members of Congress traded MRNA?
3 disclosed trades by Maria Elvira Salazar. The latest was on Sep 24, 2026.
Which institutions changed their MRNA positions?
Recent 13F filers moving the stock include Y-Intercept (Hong Kong), Kintegral Advisory, Elser Financial Planning, Banque Pictet & Cie and V-Square Quantitative Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.